Military Vestibular Assessment and Rehabilitation Advanced Conference – Fort Belvoir

September 18, 2023 to September 21, 2023

This live, in-person course (located at Fort Belvoir) is designed for clinicians who have experience with assessing and treating individuals with vestibular hypofunction and benign paroxysmal positional vertigo. The course provides advanced training in common complex disorders such as concussion, migraine, and Meniere’s disease; surgical and pharmaceutical interventions; psychogenic considerations; and other considerations when working with individuals with complex dizziness in the military. The Advanced Course features didactic instruction covering vestibular function test interpretation (Rotary Chair Testing, vHIT and VEMPs).

For instructional personnel disclosure information, click on the speaker’s bio link.

Target Audience

This activity provides continuing education for physicians, athletic trainers, occupational therapists, occupational therapy assistants, audiologists, physical therapists, and physical therapist assistants. A certificate of attendance is available for other attendees.

Learning Objectives

18 SEP 2023, 0800-1600 (ET)

  1. Defend the clinical implications of vestibulo-ocular reflex (VOR) phase with respect to pathology and compensation
  2. Appraise the benefits and limitations for advanced rotational test protocols
  3. Identify the most common signs and symptoms of Superior Semicircular Canal Dehiscence (SSCD)
  4. Evaluate a computed tomography (CT) scan for the presence of SSCD
  5. Describe the clinical criteria required for the diagnosis of Meniere’s Disease (MD)
  6. Summarize effective pharmacological and non-surgical interventions for the management of MD

 

19 SEP 2023, 0800-1600 (ET)

  1. Explain the Bárány Society’s position on ‘Cervical Dizziness’
  2. Describe an evidence-informed approach to evaluation and management of cervical dizziness
  3. Describe how to assess exercise tolerance after concussion
  4. Discuss anomalous health incidents exposures and outcomes
  5. Develop two possible methods to treat each; posterior canal and horizontal canal benign paroxysmal positional vertigo

 

20 SEP 2023, 0800-1600 (ET)

  1. Identify various tests to assess the peripheral vestibular pathways
  2. Explain the variability in test findings in chronic dizzy mTBI patients
  3. Describe psychiatric symptoms seen in patients with chronic dizziness
  4. Formulate assessment plans for vestibular and neurologic causes of chronic dizziness
  5. Explain the role of anxiety on symptom report
  6. Define state and trait anxiety
  7. Describe the functional demands on the visual, vestibular and somatosensory systems of a patient when given an example of a challenging activity
  8. Evaluate key components of a complex dizzy clinical case for differential diagnosis
  9. Invent treatment plans based on key components of a complex dizzy clinical case

 

21 SEP 2023, 0800-1600 (ET)

  1. Define fixation, pursuit, saccades, convergence, and visual motion sensitivity
  2. Identify functional limitations associated with visual deficits
  3. Explain recent Defense Technical Information Center (DTIC) report that describes vestibular coding within the active-duty population
  4. Interpret data from the DTIC report to yield insight into proper coding of vestibular dysfunction within the active-duty population
  5. Design an approach to structure and enhance communication in an interdisciplinary care team to address patient goals and outcomes in an outpatient setting
  6. Identify barriers involved with interdisciplinary care in an outpatient setting
Course summary
Available credit: 
  • 23.00 ACCME Non-Physician CME Credit
    DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education. ACCME Non-Physician CME Credit providers will be provided a certificate of participation for educational activities certified for AMA PRA Category 1 Credit™. ACCME Non-Physician CME Credit providers may receive a maximum of 23.00 hours for completing this Course activity.
  • 23.00 Physicians (ACCME)

    DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    DHA, J-7, CEPO designated this Course for a maximum of 23.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 23.00 Occupational Therapists and Occupational Therapy Assistants (AOTA)
    DHA, J-7, CEPO is an American Occupational Therapy Association (AOTA) Approved Provider of professional development (PD). PD activity approval ID# 07398. This Live course is offered at 2.3 CEUs, foundational training. AOTA does not endorse specific course content, products, or clinical procedures.
  • 23.00 American Physical Therapy Association (APTA)
    DHA, J-7, CEPO is an American Physical Therapy Association (APTA) Approved Provider of continuing education. This activity was planned by and for the health care team, and learners will receive 2.3 APTA CEUs. The assignment of APTA CEUs does not imply endorsement of specific course content, products, or clinical procedures by APTA. APTA CEUs are accepted by most state PT licensing boards. Learners are encouraged to check with their local chapter or state board to ensure that they accept APTA accredited courses for licensure renewal.
  • 23.00 Speech-Language Pathologists and Audiologists (ASHA)

    Course # is

    Level

    2.3 ASHA CEUs

    DHA, J-7, CEPO is approved by the Continuing Education board of the American Speech-Language-Hearing Association (ASHA) to provide continuing education activities in speech-language pathology, and audiology. ASHA CE Provider approval and use of the Brand Block does not imply endorsement of course content, specific products or clinical procedures.

  • 23.00 Certificate of Attendance
  • 23.00 Athletic Trainers (BOC)

    Board of Certification for the Athletic Trainer (BOC)

    DHA, J-7, CEPO (BOC AP #: P12034) is approved by the Board of Certification, Inc., to provide continuing education to Athletic Trainers (ATs). This program is eligible for a maximum of 23.00 Category A hours/Continuing Education Units (CEUs). ATs should claim only those hours actually spent in the educational program

  • 23.00 Interprofessional Continuing Education (IPCE)

    In support of improving patient care, DHA, J-7, CEPO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. This activity was planned by and for the healthcare team, and learners will receive 23.00 Interprofessional Continuing Education (IPCE) credits for learning and change.

Course opens: 
09/11/2023
Course expires: 
10/05/2023
Event starts: 
09/18/2023 - 8:00am EDT
Event ends: 
09/21/2023 - 4:00pm EDT
Add to calendar: 

Fort Belvoir, VA

Michael Schubert, D.P.T.
Presenter has no financial or non-financial relationships to disclose.

MAJ Anthony Tolisano, M.D.
Presenter has no financial or non-financial relationships to disclose.
MAJ Tolisano will be discussing off-label use purposes of Betahistine.

Christopher K. Zalewski, Ph.D.
Presenter has no financial or non-financial relationships to disclose.

Devin McCaslin, Ph.D., F-ASHA.
Presenter has no financial or non-financial relationships to disclose.

LTC Carrie Hoppes, P.T., Ph.D., NCS, OCS, ATC, CSCS.
Presenter has no financial or non-financial relationships to disclose.

John Leddy, M.D.
He must disclose his membership of the Advisory Boards for: Highmark Innovations, Neuronasal, Quadrant Biosciences, and Noggin Health. He also holds minority stock options in Highmark Innovations, 360 Concussion Care, and Noggin Health. Dr. Leddy also receives grant and/or research support from NIH and the Department of Defense (DoD).

Robin Pinto, Au.D.
Presenter has no financial or non-financial relationships to disclose.

Louis French, Psy.D.
Presenter has no financial or non-financial relationships to disclose.

Karen Lambert, D.P.T., NCS.
Presenter has no financial or non-financial relationships to disclose.

LTC Shannon Ford, M.D.
Presenter has no financial or non-financial relationships to disclose.

Jorge Serrador, Ph.D.
Presenter has no financial or non-financial relationships to disclose.

Stephanie Beauregard, M.P.T.
Presenter has no financial or non-financial relationships to disclose.

All relevant financial relationships have been resolved.

Available Credit

  • 23.00 ACCME Non-Physician CME Credit
    DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education. ACCME Non-Physician CME Credit providers will be provided a certificate of participation for educational activities certified for AMA PRA Category 1 Credit™. ACCME Non-Physician CME Credit providers may receive a maximum of 23.00 hours for completing this Course activity.
  • 23.00 Physicians (ACCME)

    DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    DHA, J-7, CEPO designated this Course for a maximum of 23.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 23.00 Occupational Therapists and Occupational Therapy Assistants (AOTA)
    DHA, J-7, CEPO is an American Occupational Therapy Association (AOTA) Approved Provider of professional development (PD). PD activity approval ID# 07398. This Live course is offered at 2.3 CEUs, foundational training. AOTA does not endorse specific course content, products, or clinical procedures.
  • 23.00 American Physical Therapy Association (APTA)
    DHA, J-7, CEPO is an American Physical Therapy Association (APTA) Approved Provider of continuing education. This activity was planned by and for the health care team, and learners will receive 2.3 APTA CEUs. The assignment of APTA CEUs does not imply endorsement of specific course content, products, or clinical procedures by APTA. APTA CEUs are accepted by most state PT licensing boards. Learners are encouraged to check with their local chapter or state board to ensure that they accept APTA accredited courses for licensure renewal.
  • 23.00 Speech-Language Pathologists and Audiologists (ASHA)

    Course # is

    Level

    2.3 ASHA CEUs

    DHA, J-7, CEPO is approved by the Continuing Education board of the American Speech-Language-Hearing Association (ASHA) to provide continuing education activities in speech-language pathology, and audiology. ASHA CE Provider approval and use of the Brand Block does not imply endorsement of course content, specific products or clinical procedures.

  • 23.00 Certificate of Attendance
  • 23.00 Athletic Trainers (BOC)

    Board of Certification for the Athletic Trainer (BOC)

    DHA, J-7, CEPO (BOC AP #: P12034) is approved by the Board of Certification, Inc., to provide continuing education to Athletic Trainers (ATs). This program is eligible for a maximum of 23.00 Category A hours/Continuing Education Units (CEUs). ATs should claim only those hours actually spent in the educational program

  • 23.00 Interprofessional Continuing Education (IPCE)

    In support of improving patient care, DHA, J-7, CEPO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. This activity was planned by and for the healthcare team, and learners will receive 23.00 Interprofessional Continuing Education (IPCE) credits for learning and change.

Please login or register to take this course.